Report on the 2018 Lung Cancer Leaders... - Lung Cancer Support

Lung Cancer Support

3,998 members2,165 posts

Report on the 2018 Lung Cancer Leadership Conference

scifiknitter profile image
scifiknitterBlogger
7 Replies

“Lung Cancer Leadership Conference” - that is an intriguing title for a conference. Free to Breathe has held this conference for several years. The event was not offered in 2017, as Free to Breathe and the Lung Cancer Research Foundation (LCRF) merged, but it was back this year, and I was invited to attend. On February 8 I flew to Atlanta to join other lung cancer advocates for three days of learning and fellowship.

This conference was both similar to and quite different from other lung cancer conferences I’ve attended. There were excellent presentations on the treatment advances made in the past several years and outlining the treatment paths currently available to patients. A panel of researchers, some of whom had received research grants from either Free to Breathe or the Lung Cancer Research Foundation, talked about the work they are doing and the challenges of doing research, plus answered some questions from the audience. The inimitable Chris Draft gave an inspiring keynote where he challenged us to build support by letting go of anger over lung cancer’s stigma, and focusing on the people who are affected by the disease; to paraphrase, “people don’t care about lung cancer, they care about you.”

The main focus of the conference was how to raise money, and most of the people attending were not survivors like myself. They were people who had lost loved ones to lung cancer and who channeled their grief into raising money for research. As an example, at one table I joined, we had six people sharing our stories and ideas, and I was the only survivor. Four people had lost family members to lung cancer, and one worked with patients.

I’ve had a taste of professional fund-raising techniques in the past, and have no doubt that we were presented with really solid, field tested ideas about how to raise money. The fundamental principles are not complicated. Walk your talk by making a self-donation. Just ask, and say “I need your help.” Use the tools available to make it as easy as possible for others to give. Be gently persistent and follow up. Successful fundraising circles back to the point that Chris Draft was making: people support people and the causes they believe in, not causes alone. As one of my bosses used to say, “It’s all relationships”.

There is no doubt that the LCRF does a great job of both raising money and funding lung cancer research. Since 2001, the LCRF and Free to Breathe together have given $34 million to fund 342 research grants. The focus is on funding young researchers, who often go on to receive larger grants from major funders like the National Institutes of Health. Getting funding and getting established are major challenges for young researchers, who aren’t going to be able to go straight from a post-doctoral fellowship to getting a big grant. The LCRF and similar organizations play a vital role in the professional development of the brilliant researchers we need to find new treatments and, eventually, a cure.

At the special dinner held on the first night, we all got a special, unexpected surprise: copies of a beautiful book, Living with Hope, telling the stories of 17 people who are living with lung cancer. I was honored to be asked to be part of this project. Several of the people in the book were at the conference, and we had a lot of fun asking each other to sign our books.

If this sounds like a conference you would like to attend, keep your eyes open for announcements of future LCRF events.

Written by
scifiknitter profile image
scifiknitter
Blogger
To view profiles and participate in discussions please or .
Read more about...
7 Replies
Denzie profile image
DenzieModeratorVolunteer

So grateful that you posted this. I’d forgotten some of what Chris said and you hit it in the part of his message my Chemo addled brain forgot. Can we just bottle him and take him with us everywhere?

It’s pretty special meeting so many who are so focused on funding research. I wish I might have been able to thank each of them personally.

Surviventhrive profile image
Surviventhrive

It was tons of fun!!! I was so happy to get to go!

PegD profile image
PegD

You captured the conference in every sense! It was an honor to have gone. Very happy to have met you, Denzie and all the other wonderful survivors, researchers, docs, staff and speakers.

Kris2018 profile image
Kris2018

Hello Anita, I found a lot of useful information from your postings. Thank you very much. My sister recently diagnosed with Exon 19 deletion Adenocarcinoma stage IV and underwent 4 cycles of Chemo and now on Erlotinib. I have bunch of questions regarding this drug. Would you please share your story? What are other medications are you taking? My sister is having facial acne (kind of rash) now. Really appreciated. Thanks.

scifiknitter profile image
scifiknitterBlogger in reply to Kris2018

Kris, you made my morning by saying that I had helped you!

I've been living with lung cancer for almost 4 years. Here is my treatment history:

Erlotinib/Tarceva - 10 months. Tolerated erlotinib well. Did have problems with rash, ended up taking a daily dose of doxycycline, which controlled the rash well. My hair stopped growing and turned frizzy and my fingernails became weak with a tendency to break. No problems with fatigue.

Clinical trial - 8 months. This was with a drug that shrank my cancer, but has been pulled from development due to toxicity and difficult market conditions.

Osimertinib/Tagrisso - 18 months. Great drug - felt well. Some rash issues, mostly from sun exposure. Some achy joint and fingernail issues.

Clinical trial - 2 months. I took a combo of erlotinib and trametinib. Not effective for me, plus side effects of fatigue and diarrhea.

Standard chemo (carboplatin/pemetrexed/bevicizumab) - 4 months. First cycle was tough, cycles 2-4 were tolerated well. Scans at the end of my 4th cycle showed shrinkage. During 5th cycle, I developed kidney damage and high blood pressure, and had to be off treatment for 2 months to recover.

Osimertinib/Tagrisso - have just started taking this again. We are not expecting any great response. We are hoping that enough resistant clones were killed off by the chemo that this treatment can hold me stable until my kidneys recover enough to consider another chemo regimen.

Other meds I take: Omeprazole and a bunch of blood pressure meds these days. I was taking a statin, but have discontinued while my kidneys are healing. I also take a probiotic, cranberry extract, and vitamin D.

I suggest that you start a new post with your questions about erlotinib. I'll be happy to answer them, and other people will be likely to contribute what they know from experience as well.

Sending best hopes to your sister.

Anita

Kris2018 profile image
Kris2018

Anita thank you very much for your reply. I am a lot of relieved from your response and keep posting in future too. Really appreciated for your best wishes to my sister. She is slowly recovering after multiple chemo and at present taking Erlotinib daily. We are planning to have PET-CT next month (last one was in January 2018). How often are you going through PET-CT since you were diagnosed?

My warm regards and happiness in your daily life! God bless you.

Kris

SusieJo1948 profile image
SusieJo1948

Hi Anita so happy to hear you are still going at it. Missed you love susie

You may also like...

Lung cancer survivor. 😊

everyone. My name is David Zyskowski. I’m a 6yr lung cancer survivor. I’m just here to learn, make...

About stages of lung cancer

mass measuring about 43*68 mm seen in the right lung base in keeping with known Carcinoma ....

Adenocarcinoma lung cancer

if the right lung and her lymph nodes are inflamed, the cancer is contained in the lungs currently....

CBD oil and lung cancer

high) to see if that will help me with getting my cancer into remission. I have heard great things...

Recurrence of lung cancer?

health problems I have been left with after the lung cancer misdiagnosis and subsequent ( but late...